Table 1.
Comparison group (n = 372) | Nondisclosure groupa(n = 166) | ||||
---|---|---|---|---|---|
Characteristic | n | % | n | % | χ2 |
Transgender | 25 | 7 | 7 | 4 | 1.2 |
African American | 350 | 94 | 149 | 90 | 3.2 |
Income <$10,000 | 235 | 64 | 86 | 52 | 6.5** |
Unemployed/disability | 297 | 79 | 120 | 71 | 4.9 |
Treated with ART | 330 | 89 | 147 | 89 | 0.1 |
Pill count adherenceb | |||||
<75% adherent | 59 | 19 | 39 | 28 | 4.4* |
<85% adherent | 105 | 34 | 54 | 39 | 0.9 |
<95% adherent | 175 | 57 | 91 | 66 | 3.0† |
Knows viral load | 212 | 57 | 91 | 55 | |
Believes undetectable viral loadc | 167 | 79 | 69 | 76 | 0.4 |
Chart undetectable viral load | 247 | 70 | 99 | 62 | 3.6* |
Chart detectable viral load | 104 | 30 | 61 | 38 | |
Tested for STI past 3 months | 182 | 49 | 92 | 55 | 1.9 |
Diagnosed STI past 3 months | 66 | 18 | 36 | 22 | 3.0 |
Alcohol use past month | 243 | 66 | 118 | 71 | 1.6 |
AUDIT >7 | 175 | 47 | 76 | 47 | 0.1 |
Drug screen positive | 196 | 55 | 94 | 58 | 0.4 |
M | SD | M | SD | t | |
---|---|---|---|---|---|
Age | 43.8 | 11.5 | 43.8 | 9.6 | 0.1 |
Years education | 12.8 | 1.7 | 13.2 | 1.7 | 2.3** |
Years HIV+ | 13.2 | 8.7 | 14.4 | 8.5 | 1.6 |
CD4 cell count | 465.4 | 271.8 | 442.1 | 265.4 | 0.9 |
HIV symptoms | 3.5 | 3.4 | 3.8 | 3.6 | 0.9 |
CESD depression | 17.9 | 6.5 | 18.3 | 6.4 | 0.6 |
Engaged in undisclosed condomless nonconcordant sex.
Among men receiving ART.
Among men stating they knew their viral load.
p < 0.1; *p < 0.05; **p < 0.01.
ART, antiretroviral therapy; AUDIT, Alcohol Use Disorders Identification Test; CESD, Centers for Epidemiological Studies Depression scale; STI, sexually transmitted infection.